close
  • home Home

  • linked_services Solutions keyboard_arrow_down

  • experiment Services keyboard_arrow_down

  • support Support & Resources keyboard_arrow_down

  • apartment Company keyboard_arrow_down

  • mail Contact

  • Solutions
    keyboard_arrow_down
  • Services
    keyboard_arrow_down
  • Support & Resources
    keyboard_arrow_down
  • Company
    keyboard_arrow_down
  • Contact
Randox Health search menu

The RIQAS Cardiac Plus EQA programme is designed to monitor the performance of 11 clinically significant cardiac markers. All samples are supplied in a lyophilised format.

Lyophilised material for enhanced stability

Submit results and view reports online via RIQAS.Net

World's largest EQA scheme ensuring peer groups are maximised

Monthly reporting for earlier identification of test system errors

Cycle Starts - January 2026

Accredited to ISO17043:2023

Get in touch to discover more

To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.

DescriptionFrequencySizeCat No
Cardiac PlusMonthly12 x 3 mlRQ9190

Parameters

  • CK, Total
  • Digoxin
  • NT proBNP
  • CK-MB Activity
  • Homocysteine
  • Troponin I
  • CK-MB Mass
  • hsCRP
  • Troponin T
  • D-dimer
  • Myoglobin

Please note, product availability may vary country to country.

Related RIQAS EQA Programmes

Cardiac

BNP

Lipid

Acusera QC
Complete QC Solutions for Results you Can Trust
RIQAS Brochure
Randox International Quality Assessment Scheme
QCMD
QCMD EQA/PT Schemes for Molecular Infectious Disease Testing.